Skip to main content
. 2022 Apr 4;6(2):166–175. doi: 10.1016/j.mayocpiqo.2022.01.002

Table 2.

Total Health Care Costs for Facility Use per Cohortab

Facility AD (n=241) nAD (n=241) Controlc (n=241)
Total cost 6825 (4940-8711) 11,312 (8554-14,067)de 8102 (6108-10,096)
Inpatient 3441 (2029-4852) 5100 (3641-6559) 4185 (2759-5611)
Outpatient 2857 (2131-3582) 5146 (3309-6984)de 2651 (2184-3118)
Skilled nursing 328 (86-570) 629 (142-1116) 605 (102-1107)
Home health 200 (77-323)e 437 (128-745) 661 (399-923)
Total cost with DMEdf 7940 (6055-9826) 11,712 (8954-14,470) 8102 (6108-10,096)
a

AD = patients with cardiovascular disease (CVD) and obstructive sleep apnea (OSA) who are adherent to continuous positive airway pressure (CPAP) therapy; DME = durable medical equipment; nAD = patients with CVD and OSA who are not adherent to CPAP therapy.

b

Group data are presented in dollars as mean (95% CI). Because controls were not diagnosed as having OSA and did not receive CPAP treatment they have no DME costs.

c

Patients with CVD but without OSA.

d

P<.05 vs AD.

e

P<.05 vs control.

f

Includes the cost of DME for CPAP therapy, estimated based on the adjusted annual cost of the CPAP machine and supplies, in addition to the cost of each of the 4 facility settings.